19p13.1 is a triple-negative-specific breast cancer susceptibility locus. - Wikidata - awgldk - TriplyDB

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

http://www.wikidata.org/entity/Q35871567

about

arrayMap: a reference resource for genomic copy number imbalances in human malignancies Genome-wide association studies identify four ER negative-specific breast cancer risk loci Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types Breast cancer subtypes and previously established genetic risk factors: a bayesian approach ZNF-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor Large-scale genotyping identifies 41 new loci associated with breast cancer risk.Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.An Integrative Genomics Approach for Associating GWAS Information with Triple-Negative Breast Cancer.Hereditary breast cancer: ever more pieces to the polygenic puzzle.Exploring genetic associations with ceRNA regulation in the human genome.Two decades after BRCA: setting paradigms in personalized cancer care and prevention Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study.How many etiological subtypes of breast cancer: two, three, four, or more?Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer.Comprehensive functional annotation of seventy-one breast cancer risk Loci.Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors.Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.New genetic variants improve personalized breast cancer diagnosis Breast Cancer Update 2014 - Focus on the Patient and the Tumour.Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers Hormone Therapy and its Effect on the Prognosis in Breast Cancer Patients.GENESIS: a French national resource to study the missing heritability of breast cancer.Leveraging Interaction between Genetic Variants and Mammographic Findings for Personalized Breast Cancer Diagnosis.DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition.Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients Inbreeding and homozygosity in breast cancer survival.Genetic susceptibility loci for subtypes of breast cancer in an African American population.A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.Genetic susceptibility to triple-negative breast cancer.Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer Novel Integrative Genomics Approach for Associating GWAS Information with Intrinsic Subtypes of Breast Cancer.Genetic evaluation of BRCA1 associated a complex genes with triple-negative breast cancer susceptibility in Chinese women.Genomic Biomarkers for Breast Cancer Risk.Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.

P2860

Q21134582-42624FE7-D55E-44D3-B6C9-F6EBBB97365E Q24622610-3D6CE9C3-921D-4F12-8B95-F5DA2A257682 Q28388497-B2144D35-E268-4ECD-9B7A-5501D88E1050 Q28397311-31A33AA4-17EB-4A85-8C58-0B2E1083850D Q28485315-27008C3A-6A18-4C48-A17B-716936A06F40 Q29416989-B4D546B2-8D06-440D-AADF-F2E8EFD860E8 Q29417050-62FBF8EE-0F52-413A-8010-638D0E998F9F Q29417100-F18EA6ED-7499-47FF-8F5C-274F4F355A23 Q30277784-CDA25D10-BCBC-40EC-ABA2-78A95656FCA0 Q33355327-6669EB73-1F3A-438A-B959-39639616C538 Q33356511-27F9E0B3-273D-4AED-8244-E225EA9EA3F8 Q33741112-C4F75DCA-ECA7-4DE9-83BC-BC7F127D6FBD Q33820594-4F3DC758-2DBA-4B67-BBC5-82E9561CEDC0 Q34022151-7F066E0B-F3C4-498A-96E5-4A466EB75D24 Q34106175-B93C3988-02CE-4982-9C82-6F2F2AC1D957 Q34460831-4C383494-BF9E-45FB-8B66-FC79DDC38CD2 Q34744860-E2CA65AD-AD3E-4D87-8A8A-AA1E97E06915 Q34898735-1236D0E8-17C4-4647-A538-4246B298AB11 Q34927615-426B22B9-897B-444B-A4B5-7BC45A8499DC Q35054455-39042062-AE02-4F89-BC95-7048E003E49A Q35082982-E7C8FDE7-887A-4B6B-AA3B-17F96657DCE2 Q35098946-098A930E-6329-4394-A3AC-F9D4E42CE227 Q35180940-419945FD-FF1C-477F-911C-D85860046714 Q35523236-E629714C-BF4B-47C1-AD75-F8313B9F236D Q35815464-3692800F-FF7F-4098-AFB2-656BACD17AA8 Q35892005-15AB049D-19DE-48D8-847E-0972646D23BE Q35917327-DB8A4494-5E8C-4AAA-9036-4022D3EF21D0 Q35993095-09A7B639-4766-4C56-82E7-A304ED8DD1A2 Q35996692-36724175-0FEC-448C-A8D6-63D39B940BB5 Q36124728-572436DF-A5A8-4DEF-B6A8-B85E99509AF8 Q36169701-92CC997C-2432-4AA2-BCB0-F1B56C1471BD Q36272742-39F354CD-E34C-4F1B-886B-7435D04E5B19 Q36514074-9EB250FD-2F14-4267-9CCB-CF0BB06BF2CF Q36693953-54DC5B3D-70BA-4C2C-891D-1217E24CCF7B Q36846498-A0CE21F2-7B85-4069-BBC3-32BB65696AAB Q36859142-D83FE7AD-124E-497D-ADC0-7793EF93AEC8 Q36873540-F9B1956B-1097-40F2-914D-D6CFF45320F0 Q36962780-37709F39-05DF-4B81-8A4A-E695CB25016D Q37242239-7008D886-105F-43B9-9318-29CD66919B51 Q37660589-9E6C2C31-A384-4B32-A338-CD86474D453E

P2860

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

http://www.wikidata.org/entity/Q35871567

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

@ast

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

@en

type

label

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

@ast

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

@en

prefLabel

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

@ast

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

@en

P1433

Q35871567-61C90A36-A03C-4357-85FC-4684A7E7C041

P1476

Q35871567-ADF98440-102A-4E7E-B8CE-6780FB51C3E3

P2093

Q35871567-0380D53C-A968-4877-AFEC-B8BF83D971B0

Q35871567-051363F2-C84A-47F3-9F28-F5D1F1A7B604

Q35871567-07D1180B-2F25-4E46-970C-392EB3115B56

Q35871567-097270DC-035B-420B-8502-3BB2D5FDF7C9

Q35871567-09A7E2F0-7450-442E-8433-27B7E0D22641

Q35871567-109A57E6-C1B2-4A7D-8C7B-AFC7C245687C

Q35871567-150104A5-09B1-4873-8FEB-7D7186168AD8

Q35871567-185943D4-0286-49D0-9AA5-C1838F8882D1

Q35871567-18EB1134-CDDF-43E2-AAA7-8EB21DBBC56A

Q35871567-193EE952-065F-4CD8-9785-BB0A533A4D08

P2860

Q35871567-01BD8299-2520-4BEA-A277-C8F260A1B6AD

Q35871567-1BAA1917-6837-43D9-87D9-9DE196A586E8

Q35871567-39C3590E-9AE4-46BD-87F7-4D4225EAEF3C

Q35871567-3E29D042-F784-48CE-9C96-450A38606691

Q35871567-4691C030-29B1-4DAA-8F14-0D1678C21069

Q35871567-4810F3AB-D3CA-45FB-80F8-255CD9D7F41B

Q35871567-4A7B5538-3C03-4EE1-BB2A-E32E0E40F621

Q35871567-4C468371-793D-4DBF-9C63-EB71503E6E2E

Q35871567-4D64B185-0C21-4A35-AFC6-0A2802651F85

Q35871567-51868F04-471D-4793-B71D-7E70383D7AE8

P304

Q35871567-39AA4F30-F0BE-4887-AEDB-8209D9735AF5

P31

Q35871567-C88756E2-D76A-47AA-B453-BC3CA7EC1368

P356

Q35871567-3202100B-1010-46D4-A6B7-B961D8748C8F

P407

Q35871567-AADC7F53-2898-4F7A-AA3B-CFD2008B4353

P433

Q35871567-382FBE3A-4F2E-4BED-9292-0FD18A317386

P478

Q35871567-D058550E-660F-418E-B06F-758765EDF439

P50

Q35871567-028CAD25-FBD5-446B-A3BE-575C2E47F7B4

Q35871567-02B78A15-56F6-4F38-B311-AD319527C3EF

Q35871567-07FA34FF-AAAC-4100-9785-6300C67EB94A

Q35871567-0AA1C3F4-0B36-4D1F-9861-C5051C8F75A0

Q35871567-0AFF30E3-2A5D-415C-81A4-3DA6391B26CD

Q35871567-0B193EC7-61DF-422B-808B-321EBA5EF98D

Q35871567-0BA78DD3-65D0-4C49-A8D8-DEB0EBA3C2F3

Q35871567-0D20F76D-82DA-46B0-B40A-7A4E6BBCDDC0

Q35871567-0D32F224-42EF-40EB-A3AA-6A6C6722046F

Q35871567-0D7E1C4A-A86E-4920-81B4-7B91420794B4

P577

Q35871567-E30ABF7A-9497-4277-AC24-E5CE90E26928

P698

Q35871567-213AC0EE-4B74-4C2A-8B2D-1B026FE10BA8

P921

Q35871567-9BC17CE6-6664-472D-8AC7-9637A8FBD4A3

P932

Q35871567-89DAA9E6-5204-4E6E-83AC-09902769DB31

P356

0008-5472.CAN-11-3364

P1433

Cancer Research

P1476

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

@en

P2093

AOCS Group

http://www.w3.org/2001/XMLSchema#string

Alexander Miron

http://www.w3.org/2001/XMLSchema#string

Alexandra Stavropoulou

http://www.w3.org/2001/XMLSchema#string

Alina Vrieling

http://www.w3.org/2001/XMLSchema#string

Andrew K Godwin

http://www.w3.org/2001/XMLSchema#string

Anne-Sophie Dieudonne

http://www.w3.org/2001/XMLSchema#string

Annie Perkins

http://www.w3.org/2001/XMLSchema#string

Arndt Hartmann

http://www.w3.org/2001/XMLSchema#string

Catriona A McLean

http://www.w3.org/2001/XMLSchema#string

Chia-Ni Hsiung

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair

MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks

MERIT40 facilitates BRCA1 localization and DNA damage repair

NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control

Triple-Negative Breast Cancer

Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

Genome-wide association study identifies five new breast cancer susceptibility loci

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.

P304

1795-1803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-11-3364

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Anne-Lise Børresen-Dale

Georgia Chenevix-Trench

Jenny Chang-Claude

Rita Schmutzler

Diether Lambrechts

Hoda Anton-Culver

Montserrat García-Closas

Gianluca Severi

P577

2012-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22331459

http://www.w3.org/2001/XMLSchema#string

P921

susceptibility locus

P932

3319792

http://www.w3.org/2001/XMLSchema#string